But What About the Others?

Image: Anne MacNamara "The history of modern science might be written without going outside the names of the Nobels." --Cosmopolitan, 19061 The Nobel Prize earned universal prestige a mere five years after its inception. With the 102nd Nobel awards this month, the Nobel Foundation continues to lavish acclaim among a thin upper crust of innovators in the life sciences. But the tradition of the science community's grumbling at the Foundation for its omissions will no doubt proceed unabated i

Written byHal Cohen
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

"The history of modern science might be written without going outside the names of the Nobels."
--Cosmopolitan, 19061

The Nobel Prize earned universal prestige a mere five years after its inception. With the 102nd Nobel awards this month, the Nobel Foundation continues to lavish acclaim among a thin upper crust of innovators in the life sciences. But the tradition of the science community's grumbling at the Foundation for its omissions will no doubt proceed unabated in the wake of this year's announcements.

"I think the Nobel has become an exaggerated symbol of scientific excellence. They are very restricted by numbers and fields," says Harriet Zuckerman, author of Scientific Elite, the classic look at the Nobel Prize, its winners, and the well-defined stratification it has caused in 20th-century science.2

THE QUEST FOR A NOBEL The Nobel statutes call for just three prizes to be awarded in six fields, none of which ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies